Foxit Supercharges AI Assistant with Multi-Document Analysis on iOS & Android
Enables Users to Boost Productivity with AI-Powered Summaries, Cross-Document Insights, and Instant Data Extraction Across Mobile Device FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ -- Foxit, a leading provider of innovative PDF and eSignature...
Vialto Partners Completes Recapitalization Transaction
Transaction Completely and Definitively Transforms Vialto's Capital Structure, Delivering a $225 Million New Money Equity Capital Investment in Vialto and a Reduction of Approximately $550 Million of Existing Debt NEW YORK, Feb. 25, 2025...
Valvoline™ Global Operations Celebrates Contributions of Mechanics Worldwide in Annual Appreciation Initiative
Global leader in automotive and industrial solutions announces sixth annual Mechanics Month, dedicating March to celebrating the hard work and hands-on expertise of mechanics around the world. LEXINGTON, Ky., Feb. 25, 2025 /PRNewswire/ -- Valvoline™...
Ascenda and Galileo Financial Technologies Collaborate to Elevate Card Loyalty Programs
Partnership combines Galileo's technology platform and Ascenda's loyalty expertise to simplify and power card loyalty programs NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Ascenda, the industry leader in loyalty-as-a-service, has partnered with Galileo...
Axiad Applauded by Frost & Sullivan for Providing Phishing-resistant Authentication with PKI-based Authentication
Axiad's PKI-based authentication enables scalability and flexibility in large-scale enterprise environments, elevates user experience and streamlines user access control SAN ANTONIO, Feb. 25, 2025 /PRNewswire/ -- Frost & Sullivan recently...
New Research Shows Surging Consumer Demand for AI-Banking Services, According to Personetics Global Survey
A survey of 2,000 bank customers reveals that 84% are likely to switch banks to access services that help them reach their financial goals NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Personetics, the company that transforms how banks build and monetize...
Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma
HEFEI, China, Feb. 25, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. ("Kangpu") today announced that the Company has received IND approval from the CDE (Center for Drug Evaluation) of China National Medical Products Administration (NMPA) for...
CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China
SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, "CARsgen Therapeutics"), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,...